Designing of Heterocyclic Compounds As Promising VEGFR2 Tyrosine Kinase Inhibitors: An Insilico Analysis. Int. J. Pharm. Sci. Drug Res. 2021, 13 (6), 685-698. https://doi.org/10.25004/IJPSDR.2021.130612.